Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2023

Nov 14, 2023

BUY
$434.7 - $599.3 $498,600 - $687,397
1,147 Added 11.18%
11,405 $6.13 Million
Q2 2023

Aug 14, 2023

BUY
$350.74 - $468.98 $243,062 - $325,003
693 Added 7.25%
10,258 $4.81 Million
Q1 2023

May 12, 2023

BUY
$310.63 - $364.82 $274,286 - $322,136
883 Added 10.17%
9,565 $3.28 Million
Q4 2022

Feb 13, 2023

BUY
$321.55 - $374.67 $353,383 - $411,762
1,099 Added 14.49%
8,682 $3.18 Million
Q3 2022

Nov 14, 2022

SELL
$296.48 - $337.87 $112,662 - $128,390
-380 Reduced 4.77%
7,583 $2.45 Million
Q2 2022

Aug 12, 2022

BUY
$278.73 - $327.27 $345,903 - $406,142
1,241 Added 18.46%
7,963 $2.58 Million
Q1 2022

May 13, 2022

BUY
$234.69 - $291.66 $1.58 Million - $1.96 Million
6,722 New
6,722 $1.93 Million

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $756B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Fund Management At Engine No. 1 LLC Portfolio

Follow Fund Management At Engine No. 1 LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fund Management At Engine No. 1 LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fund Management At Engine No. 1 LLC with notifications on news.